Transforming growth factor-β1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats

Journal of Hypertension

Volumn 18, Issue 6, 2000, Pages 733-742

  Bouillier, Hélène ^a,c   Samain, Emmanuel ^a   Miserey, Stéphanie ^b   Perret, Claudine ^a   Renaud, Jean François ^c   Safar, Michel ^a,d   Dagher, Georges ^a  

^a INSERM   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d HÔPITAL BROUSSAIS   (France)

Author keywords

Angiotensin II; Calcium; Growth factors; Hypertension; Intracellular signalling; Spontaneously hypertensive rats; Transforming growth factor 1; Vascular smooth muscle cells; Vasoactive peptides

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CALCIUM ION; FURA 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0034042579     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018060-00011     Document Type: Article

References (75)

1. 1 Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev 1996; 7:327-339.
2. 2 Kanzaki T, Shiina R, Saito Y, Zardi L, Morisaki N. Transforming growth factor-beta receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats. Diabetologia 1997; 40:383-391.
3. 3 Shanley CJ, Gharaee-Kermani M, Sarkar R, Welling TH, Kriegel A, Ford JW, et al. Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 1997; 25:446-452.
4. 4 Cucina A, Sterpetti AV, Borrelli V, Pagliei S, Cavallaro A, D'Angelo LS. Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery 1998; 123:212-217.
5. 5 Grassel S, Tan EM, Timpl R, Chu ML. Collagen type XVI expression is modulated by basic fibroblast growth factor and transforming growth factor-beta. FEBS Lett 1998; 436:197-201.
6. 6 Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension 1994; 23:593-599.
7. 7 Saltis J, Bobik A. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways. J Hypertens 1992; 10:635-643.
8. 8 Sato M, Ohsaki Y, Tobise K. Transforming growth factor-β1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 1995; 8:160-166.
9. 9 Bray P, Agrotis A, Bobik A. Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension 1998; 31:986-994.
10. 10 Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 1989; 83:1404-1408.
11. 11 Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-β1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33:271-275.
12. 12 Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31:181-188.
13. 13 Koibuchi Y, Lee WS, Gibbons GH, Pratt RE. Role of transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension 1993; 21:1046-1050.
14. 14 Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, et al. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Am J Kidney Dis 1998; 31:453-463.
15. 15 Li Q, Muragaki Y, Hatamura I, Ueno H, Ooshima A. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta. J Vasc Res 1998; 35:93-103.
16. 16 Fukuda N, Hu WY, Kubo A, Endoh M, Kishioka H, Satoh C, et al. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension 1998; 31:672-677.
17. 17 Griendling KK, Ushio-Fukai M, Lassègue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 29:366-373.
18. 18 Berridge MJ, Bootman MD, Lipp P. Calcium - a life and death signal. Nature 1998; 395:645-648.
19. 19 Tepel M, Heidenreich S, Rahn KH, Zidek W. Increased intracellular calcium response in glomerular mesangial cells from spontaneously hypertensive rats. J Hypertens 1993; 11 (suppl 5):S186-S187.
20. 20 Touyz RM, Schiffrin EL. Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats. J Hypertens 1997; 15:1431-1439.
21. 21 Samain E, Bouillier H, Perret C, Safar M, Dagher G. Angiotensin-induced calcium increase in smooth muscle cells from spontaneous hypertensive rat is regulated by actin and microtubule networks. Am J Physiol 1999; 277:H834-H841.
22. 22 Cortes SF, Lemos VS, Stoclet JC. Alterations in calcium stores in aortic myocytes from spontaneously hypertensive rats. Hypertension 1997; 29:1322-1328.
23. 23 Samain E, Bouillier H, Perret C, Safar M, Dagher G. TGF-β1 and bFGF modulate the angiotensin II-induced calcium release in vascular smooth muscle cells from normotensive and hypertensive rats (Abstract). J Physiol (London) 1998; 506P:19P
24. 2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am J Physiol 1995; 269.-H30-H36.
25. 25 Owens GK, Rovner AS, Murphy RA. Contractile protein expression and cytodifferentiation in vascular smooth muscle cells. In: Campbell JH, Campbell GR (editors): Vascular smooth muscle in culture. Boca Raton, FL: CRC Press; 1987. pp. 57-70.
26. 26 Nicholls JA, Gillespie JI, Greewell JR. The time course of intracellular calcium movements in single human umbilical vein smooth muscle cells. Pflügers Arch 1993; 425:225-232.
27. ++ signaling in cultured smooth muscle cells from human bladder. Exp Physiol 1996; 81:553-564.
28. 1A receptor transduces an amplified ANG II signal. Am J Physiol 1988; 274:E336-E345.
29. + fluxes in vascular smooth muscle cells. Pflügers Arch 1989; 415:230-234.
30. 30 Touyz RM, Tolloczko B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased palcium responses to angiotensin II but not to endothelin-1. J Hypertens 1994; 12:663-673.
31. 2+ exchange in aortic muscle cells. Am J Physiol 1989; 256:C147-C154.
32. ++ transient in VSMC from WKY and SHR. Hypertension 2000; 35:31-67.
33. 33 Ullian ME, Raymond JR, Willingham MC, Paul RV. Regulation of vascular angiotensin II receptors by EGF. Am J Physiol 1997; 273:C1241-1249.
34. 34 Chuang CC, Tan SK, Tai LK, Hsin JP, Wang FF. Evidence for the involvement of protein kinase C in the inhibition of prolactin gene expression by transforming growth factor-beta2. Mol Pharmacol 1998; 53:1054-1061.
35. 35 Roth-Eichhorn S, Eberheim A, Bode HP, Gressner AM. Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver. J Hepatol 1999; 30:612-620.
36. 36 Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res 1994; 214:528-536.
37. 2+ channel that is regulated by TGF-beta. Science 1992; 257:91-94.
38. 38 Ko Y, Stiebler H, Nickenig G, Wieczorek AJ, Vetter H, Sachinidis A. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-β on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am J Hypertens 1993; 6:496-499.
39. 39 Weiss RH, Yabes AP, Sinaee R. TGF-β and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways. Kidney Int 1995; 48:738-744.
40. 40 Janat MF, Argraves WS, Liau G. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor beta1 and by platelet-derived growth factor-BB. J Cell Physiol 1992; 151:588-595.
41. 41 Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90:456-461.
42. 42 Law F, Rizzoli R, Bonjour JP. Transforming growth factor-beta modulates the parathyroid hormone-related protein-induced responses in renal epithelial cells. Endocrinology 1993; 133:145-151.
43. 43 Awad SS, Lamb HK, Morgan JH, Dunlop W, Gillespie JI. Differential expression of ryanodine receptor RYR2 mRNA in the non-pregnant and pregnant human myometrium. Biochem J 1997: 322:777-783.
44. 44 Kimura H, Takemura H, Imoto K, Ohshika H, Mochizuki Y. Upregulation of expression of sarcoplasmic reticulum by TGF-β1 in cultured rat cardiac myocyfes. Am J Physiol 1997; 272:H2639-H2644.
45. 45 Bendhack LM, Sharma RV, Bhalla RC. Altered signal transduction in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 1992; 19 (suppl II):II142-II148.
46. 46 Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res 1997; 80:607-616.
47. 47 Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992; 71:1003-1014.
48. 2+]i elevation in the rat cardiomyocyte. Br J Pharmacol 1993; 108:6-8.
49. 49 Barker S, Kapas S, Fluck RJ, Clark AJ. Effects of the selective protein kinase C inhibitor Ro 31-7549 on human angiotensin II receptor desensitisation and intracellular calcium release. FEBS Lett 1995; 369:263-266.
50. 50 Zhang M, Turnbaugh D, Cofie D, Dogan S, Koshida H, Fugate R, et al. Protein kinase C modulation of cardiomyocyte angiotensin II and vasopressin receptor desensitization. Hypertension 1996; 27:269-275.
51. 51 Ohtsuki M, Massague J. Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction. Mol Cell Biol 1992; 12:261-265.
52. ++ mobilization is mediated by the MAP-kinase pathway. J Physiol (London) 1998; 511P:168.
53. 2+]i smooth muscle. Annu Rev Physiol 1989; 51:315-329.
54. 54 Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372:231-236.
55. 2+ entry and the regulation of smooth muscle tone. TiPS 1998; 19:266-269.
56. 56 Kuriyama H, Kitamura K, Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev 1995; 47:387-573.
57. 57 Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res 1995; 32:353-370.
58. 58 Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 1997; 77:901-930.
59. 2+ store in portal vein smooth muscle cells. J Biol Chem 1993; 268:3866-3872.
60. 2+ entry in vascular smooth muscle cells: nicardipine-sensitive and -insensitive pathways. Am J Physiol 1992; 262:C1258-C1265.
61. 2+ entry in vascular smooth muscle cells. Circulation 1997; 95:2567-2572.
62. 2+ exchange in cultured vascular smooth muscle cells. Circ Res 1988; 62:486-493.
63. 63 Zhu Z, Tepel M, Neusser M, Zidek W. Transforming growth factor β1 modulates angiotensin II-induced calcium influx in vascular smooth muscle. Eur J Clin Invest 1995; 25: 31-32.
64. 64 Libby J, Martinez R, Weber MJ. Tyrosine phosphorylation in cells treated with transforming growth factor-beta. J Cell Physiol 1986; 129:159-166.
65. 65 Like B, Massague J. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J Biol Chem 1986; 261:13426-13429.
66. 66 Murthy US, Anzano MA, Stadel JM, Greig R. Coupling of TGF-beta-induced mitogenesis to G-protein activation in AKR-2B cells. Biochem Biophys Res Commun 1988; 152:1228-1235.
67. 67 Marcelli C, Yates AJ, Mundy GR. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 1990; 5:1087-1096.
68. 68 Muldoon LL, Rodland KD, Magun BE. Transforming growth factor beta and epidermal growth factor alter calcium influx and phosphatidylinositol turnover in rat-1 fibroblasts. J Biol Chem 1988; 263:18834-18841.
69. 69 Ghosh TK, Bian J, Short AD, Ryback SL, Gill DL Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J Biol Chem 1991; 266:24690-24697.
70. 70 Waldron RT, Short AD, Meadows JJ, Gosh TK, Gill DL. Endoplasmic reticulum calcium pump expression and control of cell growth. J Biol Chem 1994; 269:11927-11933.
71. 2+ response amplitude and duration. Nature 1997; 386:855-858.
72. 72 Hardingham GE, Chawla S, Johnson CM, Bading H, Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997; 385:260-265.
73. 73 Bruschi G, Bruschi ME, Capelli P, Regolisti G, Borghetti A. Increased sensitivity to protein kinase C activation in aortas of spontaneously hypertensive rats. J Hypertens 1988; 6 (suppl 4):S248-S251.
74. 74 Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 1989; 13:589-597.
75. 75 Gros R, Benovic JL, Tan CM, Feldman RD. G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 1997; 99:2087-2093.